A SRC-like inactive conformation in the abl tyrosine kinase domain.
Levinson, N.M., Kuchment, O., Shen, K., Young, M.A., Koldobskiy, M., Karplus, M., Cole, P.A., Kuriyan, J.(2006) PLoS Biol 4: 753-767
- PubMed: 16640460 
- DOI: 10.1371/journal.pbio.0040144
- Primary Citation of Related Structures:  
2G1T, 2G2F, 2G2H, 2G2I - PubMed Abstract: 
The improper activation of the Abl tyrosine kinase results in chronic myeloid leukemia (CML). The recognition of an inactive conformation of Abl, in which a catalytically important Asp-Phe-Gly (DFG) motif is flipped by approximately 180 degrees with respect to the active conformation, underlies the specificity of the cancer drug imatinib, which is used to treat CML ...